Intervention Insights is dedicated to giving patients the best possible chance to beat cancer by aligning the interests of providers, molecular labs, and payors in the appropriate, scalable use of precision medicine. Our innovative technology platform, Trapelo™ provides real-time, evidence-based information and full transparency to help oncologists make patient-based decisions with reimbursement assurance from the start. WHO WE ARE Almost everyone at Intervention Insights has a story about a loved one or friend who has been touched by cancer. Our mission is to address the challenges that result from rapid changes in the science, technology and business of next-generation cancer care. To us, that means always putting patients first. WHAT WE BELIEVE We believe Trapelo is a win-win solution for oncologists, practices, labs, and payors that need real-time, evidence-based information and full transparency to make patient-based decisions. Everyone wants the best care for cancer patients. By providing access to the latest clinical evidence and facilitating network-wide collaboration, Trapelo makes it possible. WHY WORK WITH US The more oncologists, practices, molecular labs and payors align through Trapelo, the more streamlined and cost-effective molecular testing for cancer care will become, and the faster cancer patients will receive appropriate options for care when time matters most. CONTACT US Ready to learn more? Visit GetTrapelo.com today to schedule a demo or contact us at 617.250.7572, info@interventioninsights.com.
Looking for a particular Intervention Insights employee's phone or email?
The Intervention Insights annual revenue was $6.4 million in 2026.
1 people are employed at Intervention Insights.
Intervention Insights is based in Grand Rapids, Michigan.
The NAICS codes for Intervention Insights are [517110, 51, 5171, 517, 51711].
The SIC codes for Intervention Insights are [737, 7375, 73].